Poststroke Depression in Hemorrhagic Stroke
Summary
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Depression |
5.67; 5.00 | — |
| SECONDARY Anxiety |
8.00; 9.50 | — |
| SECONDARY Fatigue |
2.71; 1.39 | — |
| SECONDARY Healthcare Utilization |
5.67; 23 | — |
| SECONDARY Social Support |
6.80; 4.75 | — |
| SECONDARY Sleep Disturbance |
48.97; 44.85 | — |
| SECONDARY Function |
100; 100 | — |
Eligibility Criteria
Inclusion Criteria
Patients 18-85 years of age aged 18 years and older will be included.
Patients admitted for subarachnoid hemorrhage from a ruptured cerebral aneurysm will be included.
Only patients who provide informed consent will be included.
Exclusion Criteria
Non-English speaking patients will be excluded.
Patients currently receiving therapy for depression or related mental health diagnoses before admission will be excluded.
Patients with medical contraindications to fluoxetine therapy will be excluded.
Pregnant patients or patients considering pregnancy during the trial period at the time of consent will be excluded.
Patients with active psychosis will be excluded.
Patients who are incarcerated or in police custody will be excluded.
Patients with a comorbidity or cognitive impairment (as determined by a recruiter-administered Montreal Cognitive Assessment; Patients scoring >26 are considered of appropriate cognitive function for consent) that precludes informed consent and participation in the research interviews will be excluded.
Data sourced from ClinicalTrials.gov (NCT03826875). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.